Leveraging big data to transform target selection and drug discovery

Abstract

The advances of genomics, sequencing, and high throughput technologies have led to the creation of large volumes of diverse datasets for drug discovery. Analyzing these datasets to better understand disease and discover new drugs is becoming more common. Recent open data initiatives in basic and clinical research have dramatically increased the types of data available to the public. The past few years have witnessed successful use of big data in many sectors across the whole drug discovery pipeline. In this review, we will highlight the state of the art in leveraging big data to identify new targets, drug indications, and drug response biomarkers in this era of precision medicine.

The Neuroimmune Transcriptome and Alcohol Dependence: Potential for Targeted Therapies

“…There is growing support for computational approaches to drug repurposing as outlined in recent reviews [136][137][138][139]. The NIH is currently funding multiple research institutions to refine and extend a database of human cellular responses.…”

Search for in-Silico Applications in Drug Discovery and Applications of Different Disciplines in It: A Survey

“…Some of the existing works relating to solution to this problem are given in [26] - [29]; these works are using machine learning approach, artificial intelligence, pattern matching and the software Hadoop to solve the big data problem. Big data also helps in selecting drug target [30] and in virtual screening [31]. A method for identification of drug target path on biomedical data has been given in [32].…”

Update on Data Reuse in Health Care

“…Reuse of data for research may have the most far-reaching impact on the health of our citizens by not only speeding the design and execution of clinical trials [11] but also assisting in the discovery of new knowledge [12][13][14]. …”